This study examined the prevalence of acute and chronic myocardial injury according to standard criteria in patients after acute ischaemic stroke (AIS) and its relation to stroke severity and short-term prognosis. Between August 2020 and August 2022, 217 consecutive patients with AIS were enrolled. Plasma levels of high-sensitive cardiac troponin I (hs-cTnI) were measured in blood samples obtained at the time of admission and 24 and 48 h later. The patients were divided into three groups according to the Fourth Universal Definition of Myocardial Infarction: no injury, chronic injury, and acute injury. Twelve-lead ECGs were obtained at the time of admission, 24 and 48 h later, and on the day of hospital discharge. A standard echocardiographic examination was performed within the first 7 days of hospitalization in patients with suspected abnormalities of left ventricular function and regional wall motion. Demographic characteristics, clinical data, functional outcomes, and all-cause mortality were compared between the three groups. The National Institutes of Health Stroke Scale (NIHSS) at the time of admission and the modified Rankin Scale (mRS) 90 days following hospital discharge were used to assess stroke severity and outcome. Elevated hs-cTnI levels were measured in 59 patients (27.2%): 34 patients (15.7%) had acute myocardial injury and 25 patients (11.5%) had chronic myocardial injury within the acute phase after ischaemic stroke. An unfavourable outcome, evaluated based on the mRS at 90 days, was associated with both acute and chronic myocardial injury. Myocardial injury was also strongly associated with all-cause death, with the strongest association in patients with acute myocardial injury, at 30 days and at 90 days. Kaplan-Meier survival curves showed that all-cause mortality was significantly higher in patients with acute and chronic myocardial injury than in patients without myocardial injury (P < 0.001). Stroke severity, evaluated with the NIHSS, was also associated with acute and chronic myocardial injury. A comparison of the ECG findings between patients with and without myocardial injury showed a higher occurrence in the former of T-wave inversion, ST segment depression, and QTc prolongation. In echocardiographic analysis, a new abnormality in regional wall motion of the left ventricle was identified in six patients. Chronic and acute myocardial injury with hs-cTnI elevation after AIS are associated with stroke severity, unfavourable functional outcome, and short-term mortality.

Cardiocenter Charles University 3rd Faculty of Medicine Ruská 87 100 00 Prague Czech Republic

Department of Neurology 3rd Faculty of Medicine University Hospital Kralovske Vinohrady Charles University Ruská 87 100 00 Prague Czech Republic

Medtronic Czechia Partner of INTERCARDIS Prosecká 852 66 190 00 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23009648

003      

CZ-PrNML

005      

20230721095516.0

007      

ta

008      

230707s2023 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1093/eurheartjsupp/suad104 $2 doi

035    __

$a (PubMed)37234232

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Mihalovic, Michal $u Cardiocenter, Charles University-Third Faculty of Medicine, Ruská 87, 100 00 Prague, Czech Republic

245    10

$a Prevalence of myocardial injury in patients after acute ischaemic stroke according to standard criteria / $c M. Mihalovic, P. Mikulenka, H. Línková, M. Neuberg, I. Štětkářová, T. Peisker, D. Lauer, P. Tousek

520    9_

$a This study examined the prevalence of acute and chronic myocardial injury according to standard criteria in patients after acute ischaemic stroke (AIS) and its relation to stroke severity and short-term prognosis. Between August 2020 and August 2022, 217 consecutive patients with AIS were enrolled. Plasma levels of high-sensitive cardiac troponin I (hs-cTnI) were measured in blood samples obtained at the time of admission and 24 and 48 h later. The patients were divided into three groups according to the Fourth Universal Definition of Myocardial Infarction: no injury, chronic injury, and acute injury. Twelve-lead ECGs were obtained at the time of admission, 24 and 48 h later, and on the day of hospital discharge. A standard echocardiographic examination was performed within the first 7 days of hospitalization in patients with suspected abnormalities of left ventricular function and regional wall motion. Demographic characteristics, clinical data, functional outcomes, and all-cause mortality were compared between the three groups. The National Institutes of Health Stroke Scale (NIHSS) at the time of admission and the modified Rankin Scale (mRS) 90 days following hospital discharge were used to assess stroke severity and outcome. Elevated hs-cTnI levels were measured in 59 patients (27.2%): 34 patients (15.7%) had acute myocardial injury and 25 patients (11.5%) had chronic myocardial injury within the acute phase after ischaemic stroke. An unfavourable outcome, evaluated based on the mRS at 90 days, was associated with both acute and chronic myocardial injury. Myocardial injury was also strongly associated with all-cause death, with the strongest association in patients with acute myocardial injury, at 30 days and at 90 days. Kaplan-Meier survival curves showed that all-cause mortality was significantly higher in patients with acute and chronic myocardial injury than in patients without myocardial injury (P < 0.001). Stroke severity, evaluated with the NIHSS, was also associated with acute and chronic myocardial injury. A comparison of the ECG findings between patients with and without myocardial injury showed a higher occurrence in the former of T-wave inversion, ST segment depression, and QTc prolongation. In echocardiographic analysis, a new abnormality in regional wall motion of the left ventricle was identified in six patients. Chronic and acute myocardial injury with hs-cTnI elevation after AIS are associated with stroke severity, unfavourable functional outcome, and short-term mortality.

590    __

$a NEINDEXOVÁNO

655    _2

$a časopisecké články $7 D016428

700    1_

$a Mikulenka, Petr $u Department of Neurology, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Ruská 87, 100 00 Prague, Czech Republic

700    1_

$a Línková, Hana $u Cardiocenter, Charles University-Third Faculty of Medicine, Ruská 87, 100 00 Prague, Czech Republic

700    1_

$a Neuberg, Marek $u Medtronic Czechia, Partner of INTERCARDIS, Prosecká 852/66, 190 00 Prague, Czech Republic

700    1_

$a Štětkářová, Ivana $u Department of Neurology, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Ruská 87, 100 00 Prague, Czech Republic

700    1_

$a Peisker, Tomáš $u Department of Neurology, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Ruská 87, 100 00 Prague, Czech Republic

700    1_

$a Lauer, David $u Department of Neurology, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Ruská 87, 100 00 Prague, Czech Republic

700    1_

$a Tousek, Petr $u Cardiocenter, Charles University-Third Faculty of Medicine, Ruská 87, 100 00 Prague, Czech Republic

773    0_

$w MED00005247 $t European heart journal supplements : journal of the European Society of Cardiology $x 1520-765X $g Roč. 25, Suppl E (2023), s. E3-E9

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37234232 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230707 $b ABA008

991    __

$a 20230721095509 $b ABA008

999    __

$a ok $b bmc $g 1958451 $s 1195912

BAS    __

$a 3

BAS    __

$a PreBMC-PubMed-not-MEDLINE

BMC    __

$a 2023 $b 25 $c Suppl E $d E3-E9 $e 20230524 $i 1520-765X $m European heart journal supplements $n Eur Heart J Suppl $x MED00005247

LZP    __

$a Pubmed-20230707